Genentech profit up on Avastin, Rituxan
240917
Genentech Inc.  on Wednesday said second-quarter profit rose 41 percent, fueled by growth from key cancer drugs Avastin and Rituxan, and it boosted its full-year profit forecast.
67048
Eli Lilly and Co  on Tuesday said fourth-quarter profit rose on lower taxes and better-than-expected sales of its medicines, including newer treatments for depression, diabetes and cancer.
259915
Quest Diagnostics Inc. DGX.N, the  leading U.S provider of diagnostics medical testing, on Monday  said its quarterly net profit rose, as higher revenue  outweighed the effects of the recent hurricanes in Florida.
608900
Biotechnology company Genentech Inc   said on Monday its fourth-quarter profit rose 6.4  percent, but sales of several drugs, including blockbuster  cancer drug Avastin, fell short of investor expectations,  sending the company's shares lower.
578661
Basel, Switzerland, November 30 (ots/PRNewswire) - Roche and Genentech, Inc., announced today that Avastin(TM) (bevacizumab, rhuMAb-VEGF), a new innovative anti-angiogenesis drug, has shown for the first time that it significantly increases survival in
438480
Credit Suisse First Boston said that an announcement from Onyx Pharmaceuticals (nasdaq: ONXX - news - people ) is &quot;good news&quot; for Genentech (nyse: DNA - news - people ) and its Avastin treatment.
60402
Biogen Idec Inc. BIIB.O on Monday  reported a quarterly profit on sales of its multiple sclerosis  and cancer drugs versus a year-ago loss, but said costs will  rise in 2005, trimming earnings growth.
346082
Eli Lilly and Co  on Tuesday said fourth-quarter profit rose on lower taxes and better-than-expected sales of its medicines, including its newer treatments for depression, diabetes and cancer.
732908
The company said fourth-quarter earnings rose 17 percent on higher sales of its Enbrel arthritis drug and Prevnar vaccine, but said generic competition would hit 2008 profit.
177682
Genentech appears to have resolved a dispute with ophthalmologists that will allow its drug Avastin to continue to be used to treat eye diseases, boths sides said.
75723
Genentech appears to have resolved a dispute with ophthalmologists over use of  the companyâs drug Avastin   to treat eye diseases.
763441
Genentech Inc. (DNA.N: Quote, Profile, Research) on Wednesday posted a 50 percent rise in quarterly profit and raised its full-year earnings forecast on strong sales of
244313
BASEL, Switzerland  - Core net profit at Roche  Holding AG rose by less than expected in 2004 despite strong  sales of cancer drugs, as products such as flu drug Tamiflu  suffered a weaker fourth quarter.
194383
Biotechnology company Genentech Inc  said on Monday its fourth-quarter profit rose 6.4 percent, but sales of several drugs, including blockbuster cancer drug Avastin, fell short of investor expectations, sending the company's shares lower.
382374
The Swiss pharmaceutical giant, Novartis, on Tuesday announced an 18 percent increase in second quarter net profit to 2.02 billion dollars (1.46 billion euros) and reiterated its forecast of record profits this year.
249246
Genentech and Biogen Idec's drug shows positive results against multiple sclerosis.
308820
Abbott Laboratories Inc.  on Tuesday said its fourth-quarter profit rose 3.2 percent on higher sales of its prescription drugs, including its popular new treatment for rheumatoid arthritis, Humira.